Bearish flow noted in FibroGen with 1,525 puts trading, or 1.2x expected. Most active are Jul-23 2.5 puts and Jul-23 7.5 puts, with total volume in those strikes near 540 contracts. The Put/Call Ratio is 76.25, while ATM IV is up nearly 15 points on the day. Earnings are expected on August 7th.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on FGEN:
- FibroGen put volume heavy and directionally bearish
- FGEN Slides after DMD Candidate Fails In Phase 3 Trial
- FibroGen Announces Topline Results from LELANTOS-1 Phase 3 Clinical Study of Pamrevlumab in Non-Ambulatory Patients with Duchenne Muscular Dystrophy
- FibroGen to Present at Jefferies Global Healthcare Conference
- FibroGen Announces Positive Topline Results from China Pivotal Phase 3 Clinical Trial of Roxadustat for the Treatment of Chemotherapy Induced Anemia